For the last episode of the year, we are doing a deep dive into what AUTM’s 2022 advocacy activities have consisted of. It was a fruitful and energizing year for AUTM (though not without its fair share of challenges), and there is nobody better than today’s guest, Mike Waring, to share this overview with us.Mike has been involved in Washington politics for over 40 years and is currently a consultant to AUTM on advocacy issues and chair of AUTM’s Public Policy Advisory Committee.In this informative and insightful episode, we discuss the benefits of the CHIPS and Science Act, the problems with the DOE’s Declaration of Exceptional Circumstances, AUTM’s approach to preventing unrestricted access to patented therapeutics and diagnostics, and more. This conversation will leave you feeling grateful for the work that AUTM is doing and excited about the year ahead. In This Episode:[00:50] Introducing today’s guest, AUTM consultant Mike Waring. [01:55] Examples of AUTM’s advocacy activities in 2022. [02:16] Some of the challenges that AUTM faced over the past year.[03:34] Mike explains how the CHIPS and Science Act came into being and how it will benefit technology transfer offices. [08:37] Understanding the DOE’s Declaration of Exceptional Circumstances and how AUTM has responded to it. [11:49] The issue of march-in rights and AUTM’s approach to pushing back against them.[15:35] The role that AUTM has played in preventing unrestricted access to patented therapeutics and diagnostics.[18:27] What the Pride in Patent Ownership Act is and why it is a dangerous proposal.[22:16] Reasons for optimism with respect to Section 101. [26:40] Mike’s thoughts on what technology transfer offices should focus on in the coming years.[30:25] Details about the special panel that Mike is going to be a part of at the 2023 AUTM Annual Meeting.Resources:2023 AUTM Annual Meeting

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related